We trim our target price (TP) by 5.8% but upgrade our rating from MARKET PERFORM to OUTPERFORM as BMI’s share price has decreased by 16.7% in the last three months. Our lower TP is mainly due to a 4.1% average decrease in our 2021-2025F net income. We tri